IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v7y2009i3p193-205.html
   My bibliography  Save this article

The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK

Author

Listed:
  • Zhimei Liu
  • Quan Doan
  • Jennifer Malin
  • Robert Leonar

Abstract

In this UK analysis, pegfilgrastim appears to dominate 11-day use of filgrastim. The value of pegfilgrastim versus 6-day filgrastim at £4161-8526/QALY was very favourable compared with the commonly used threshold in the UK. In this setting, primary prophylaxis with pegfilgrastim may be cost effective compared with filgrastim. Copyright Adis Data Information BV 2009

Suggested Citation

  • Zhimei Liu & Quan Doan & Jennifer Malin & Robert Leonar, 2009. "The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK," Applied Health Economics and Health Policy, Springer, vol. 7(3), pages 193-205, September.
    • Handle: RePEc:spr:aphecp:v:7:y:2009:i:3:p:193-205
    DOI: 10.1007/BF03256152
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/BF03256152
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/BF03256152?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kelly Fust & Xiaoyan Li & Michael Maschio & Guillermo Villa & Anju Parthan & Richard Barron & Milton C. Weinstein & Luc Somers & Caroline Hoefkens & Gary H. Lyman, 2017. "Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma," PharmacoEconomics, Springer, vol. 35(4), pages 425-438, April.
    2. Sandmann, Frank G. & Franken, Margreet G. & Steenhoek, Adri & Koopmanschap, Marc A., 2013. "Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time," Health Policy, Elsevier, vol. 112(3), pages 285-296.
    3. Bradford Hirsch & Gary Lyman, 2012. "Pharmacoeconomics of the Myeloid Growth Factors," PharmacoEconomics, Springer, vol. 30(6), pages 497-511, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:7:y:2009:i:3:p:193-205. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.